Skip to main content
Log in

Communicating the New Pharmacovigilance Landscape

  • Editorial
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Uppsala Monitoring Centre. Effective communications in pharmacovigilance [online]. Available from URL: http://who-umc.org/DynPage.aspx?id=105830&mn1=7347&mn2=7259&mn3=7297&mn4=7498 [Accessed 2012 Oct 24]

  2. Uppsala Monitoring Centre. Dialogue in pharmacovigilance: more effective communication [online]. Available from URL: http://www.who-umc.org/DynPage.aspx?id=105831&mn1=7347&mn2=7259&mn3=7297&mn4=7499 [Accessed 2012 Oct 24]

  3. WHO, Office of the United Nations High Commissioner for Human Rights. The right to health. Fact sheet 31, page 7 [online]. Available from URL: http://www.ohchr.org/Documents/Publications/Factsheet31.pdf [Accessed 2012 Oct 24]

  4. Smith CM. Origin and uses of primum non nocere: above all, do no harm!. J Clin Pharmacol 2005; 45(4): 371–7

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The author has no conflicts of interest that are directly relevant to the content of this editorial.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Ralph Edwards.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edwards, I.R. Communicating the New Pharmacovigilance Landscape. Drug Saf 35, 1085–1089 (2012). https://doi.org/10.1007/BF03261995

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03261995

Navigation